New Clinical Resource Presents the Latest Evidence of Effective Procedures for Fluid Management
London, United Kingdom, October 08, 2016 --(PR.com)-- EPGonline.org is pleased to announce the latest addition to its range of educational resources for healthcare professionals. The Fluid Management Knowledge Centre is intended as a learning tool to educate healthcare professionals on effective procedures for fluid management in a selection of clinical scenarios.
Currently, the choice of intravenous fluids used for the resuscitation of acutely ill patients in clinical practice is determined mainly by clinician preference(1). However, emerging evidence from multiple randomised controlled trials (RCTs) indicates that the choice of resuscitation fluid affects patient outcomes(1–3). Consequently, the primary purpose of the Fluid Management Knowledge Centre is to improve patient survival rates by providing information on the pros and cons of different types of intravenous fluids in a range of clinical scenarios.
The Fluid Management Knowledge Centre is accessible at the following address: https://www.epgonline.org/fluid-management-knowledge-centre/en/index.cfm. In order to access the resource in full, users should register for free via the registration form on the epgonline.org homepage.
Information is divided into four main sections. The "Overview" section presents options for intravenous fluids and key clinical scenarios where fluid management may be required such as in the treatment of sepsis and septic shock, liver cirrhosis and cardiac surgery. A "Publications digest" section summarises important publications in a short, easily digestible format. An "Events" section has expert videos recorded during United European Gastroenterology Week (UEGW) 2013 and a Key Issues Dialogue, which features a panel of experts discussing the use of albumin for volume replacement. Lastly, the "Resources" section contains links to treatment guidelines and key publications, and educational slide sets including a comparison between albumin and hydroxyethyl starch (HES) for volume replacement.
Dr Toby Galbraith, Director of Content Strategy for epgonline.org, said: “Fluid management is an often overlooked area of medicine, but can have a huge impact on survival in seriously ill patients. We hope that this new educational resource provides a useful primer of best practice and allows our audience to be more confident in their clinical choices.” The Fluid Management Knowledge Centre has been developed by epgonline.org in collaboration with CSL Behring, with content provided by CSL Behring, and is not intended for healthcare professionals outside Europe.
Notes to Editors:
EPG Health Media is a digital communications company and publisher of epgonline.org, which provides healthcare professionals worldwide with free access to a wealth of clinical content, carefully developed and curated from trustworthy sources and conveniently organised by disease, medical specialty and information type. Content includes localised prescription drug information, disease-focused 'Learning Zones', treatment guidelines, drug and industry news, clinical trial information and journal article abstracts.
CSL Behring is a global leader in the plasma protein biotherapeutics industry with a company history dating back to 1904. They research, develop, manufacture and market biotherapies, which are used to treat serious and rare conditions, including coagulation (bleeding) disorders such as haemophilia and von Willebrand disease and immune deficiencies. Biotherapies are also used in the rapid reversal of warfarin and to prevent haemolytic disease in new-born infants resulting from Rh factor incompatibilities. CSL Behring employs more than 9,000 people in 19 countries.
The Fluid Management Knowledge Centre is not intended for healthcare professionals outside Europe.
References:
(1)Myburgh JA, Mythen MG. Resuscitation fluids. N Engl J Med. 2013;369:1243-51.
(2)McDermid RC, Raghunathan K, Romanovsky A, Shaw AD, Bagshaw SM. Controversies in fluid therapy: Type, dose and toxicity. World J Crit Care Med. 2014;3:24-33.
(3)Myburgh JA. Fluid resuscitation in acute medicine: what is the current situation? J Intern Med. 2015;277:58-68.
Currently, the choice of intravenous fluids used for the resuscitation of acutely ill patients in clinical practice is determined mainly by clinician preference(1). However, emerging evidence from multiple randomised controlled trials (RCTs) indicates that the choice of resuscitation fluid affects patient outcomes(1–3). Consequently, the primary purpose of the Fluid Management Knowledge Centre is to improve patient survival rates by providing information on the pros and cons of different types of intravenous fluids in a range of clinical scenarios.
The Fluid Management Knowledge Centre is accessible at the following address: https://www.epgonline.org/fluid-management-knowledge-centre/en/index.cfm. In order to access the resource in full, users should register for free via the registration form on the epgonline.org homepage.
Information is divided into four main sections. The "Overview" section presents options for intravenous fluids and key clinical scenarios where fluid management may be required such as in the treatment of sepsis and septic shock, liver cirrhosis and cardiac surgery. A "Publications digest" section summarises important publications in a short, easily digestible format. An "Events" section has expert videos recorded during United European Gastroenterology Week (UEGW) 2013 and a Key Issues Dialogue, which features a panel of experts discussing the use of albumin for volume replacement. Lastly, the "Resources" section contains links to treatment guidelines and key publications, and educational slide sets including a comparison between albumin and hydroxyethyl starch (HES) for volume replacement.
Dr Toby Galbraith, Director of Content Strategy for epgonline.org, said: “Fluid management is an often overlooked area of medicine, but can have a huge impact on survival in seriously ill patients. We hope that this new educational resource provides a useful primer of best practice and allows our audience to be more confident in their clinical choices.” The Fluid Management Knowledge Centre has been developed by epgonline.org in collaboration with CSL Behring, with content provided by CSL Behring, and is not intended for healthcare professionals outside Europe.
Notes to Editors:
EPG Health Media is a digital communications company and publisher of epgonline.org, which provides healthcare professionals worldwide with free access to a wealth of clinical content, carefully developed and curated from trustworthy sources and conveniently organised by disease, medical specialty and information type. Content includes localised prescription drug information, disease-focused 'Learning Zones', treatment guidelines, drug and industry news, clinical trial information and journal article abstracts.
CSL Behring is a global leader in the plasma protein biotherapeutics industry with a company history dating back to 1904. They research, develop, manufacture and market biotherapies, which are used to treat serious and rare conditions, including coagulation (bleeding) disorders such as haemophilia and von Willebrand disease and immune deficiencies. Biotherapies are also used in the rapid reversal of warfarin and to prevent haemolytic disease in new-born infants resulting from Rh factor incompatibilities. CSL Behring employs more than 9,000 people in 19 countries.
The Fluid Management Knowledge Centre is not intended for healthcare professionals outside Europe.
References:
(1)Myburgh JA, Mythen MG. Resuscitation fluids. N Engl J Med. 2013;369:1243-51.
(2)McDermid RC, Raghunathan K, Romanovsky A, Shaw AD, Bagshaw SM. Controversies in fluid therapy: Type, dose and toxicity. World J Crit Care Med. 2014;3:24-33.
(3)Myburgh JA. Fluid resuscitation in acute medicine: what is the current situation? J Intern Med. 2015;277:58-68.
Contact
EPG Health Media
Kristie Marchant
01892 526 776
www.epghealthmedia.com
Kristie Marchant
01892 526 776
www.epghealthmedia.com
Contact
Categories